| Ytd | -4.45% | |
| 1y | -14.52% |
| Open | 61.50 | Prev Close | 61.74 | Low | 61.09 | High | 62.41 | Mkt Cap | 5.84B |
| Vol | 0.00 | Avg Vol | 946.91K | EPS | 4.20 | P/E | 14.61 | Forward P/E | 13.51 |
| Beta | 0.80 | Short Ratio | 6.62 | Inst. Own | 103.67% | Dividend | 1.44 | Div Yield | 2.33 |
| Ex Div Date | 08-11 | Earning | 07-30 | 50-d Avg | 53.12 | 200-d Avg | 60.72 | 1yr Est | 79.00 |
Innovation Passport award designed to support accelerated time to market and help expedite patient a
Dolby targets a sharp fiscal Q4 rebound as content deals, auto Atmos growth and licensing gains face
Dolby's discounted valuation and $756 million cash balance support its long-term case as premium for
Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cy
Dolby beat on earnings but missed on sales last night. Both earnings and sales declined year over ye
U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other g
DLB beat Q3 earnings estimates despite lower revenue, then forecast strong Q4 growth backed by video
Dolby Laboratories NYSE: DLB reported third-quarter fiscal 2026 revenue of $305 million, within its
Dolby Laboratories (DLB) came out with quarterly earnings of $0.69 per share, beating the Zacks Cons
Although the revenue and EPS for Dolby Laboratories (DLB) give a sense of how its business performed
Dolby Laboratories, Inc. (DLB) Q3 2026 Earnings Call Transcript
SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the
For the second quarter of 2026, Aristotle Capital's Global Equity WM Composite posted a total return
Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x
SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immer
BOSTON, July 14, 2026 (GLOBE NEWSWIRE) -- CervoMed Announces New Clinical, Plasma Biomarker and Imag
Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FD
- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Di
Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are l
Arista Networks (NYSE: ANET), a leader in modern AI fabric networking, today announced the Arista [u
Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026⢠Coverage on Peacock, a Stre
Dolby Laboratories, Inc. (DLB) Presents at 2026 Baird Global Consumer, Technology & Services Confere
U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on
Companies Reporting Before The Bell • Children's Place (NASDAQ:PLCE) is projected to report qua
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
On Tuesday, 838 companies hit new 52-week lows.
During Monday's session, 402 companies made new 52-week lows.
On Tuesday, 456 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report
On Monday, 524 stocks hit new 52-week lows.
During Tuesday's trading, 505 companies set new 52-week lows.
On Friday, 313 companies hit new 52-week lows.
On Thursday, 147 companies achieved new lows for the year.
On Monday, 71 stocks hit new 52-week lows.
On Friday, 209 companies set new 52-week lows.
Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterl
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarter
Monday's morning session saw 277 companies set new 52-week highs.
Before 10 a.m. ET on Tuesday, 165 companies set new 52-week highs.